Penn Virginia Corporation Stock News History

PVA

NYSE

$6.28

Penn Virginia Corporation Acquires Additional Eagle Ford Shale Acreage (10:39 AM - Businesswire)

"... events changes in governmental regulations or enforcement practices especially with respect to environmental Health and safety matters uncertainties relating to general domestic and international ec...

10/03/2012

Last PPS:

$6.25

Gain/Loss:

-0.56%

[

-0.56%

Day

]

Volume:

79.9k

Interest Level:

PVA

NYSE

$6.20

Penn Virginia Corporation Announces New Credit Facility and Provides an Update on Financial Liquidit (7:06 AM - Businesswire)

No Preview Available.

10/01/2012

Last PPS:

$6.15

Gain/Loss:

-0.81%

[

-0.81%

Day

]

Volume:

604.4k

Interest Level:

PVA

NYSE

$6.42

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2012 Results (4:01 PM - Businesswire)

"...rance germany portugal and the u k and is awaiting authorization in italy and spain the united states Food And Drug Administration fda has cleared psivida 39 s investigational new drug application...

09/24/2012

Last PPS:

$6.42

Gain/Loss:

[

0.00%

Day

]

Volume:

321.5k

Interest Level:

PVA

NYSE

$7.06

pSivida Corp. Announces Fourth Quarter and Fiscal Year 2012 Financial Results Release Date and Conference (12:33 PM - Businesswire)

09/17/2012

Last PPS:

$6.87

Gain/Loss:

-2.69%

[

-2.69%

Day

]

Volume:

513.4k

Interest Level:

PVA

NYSE

$5.48

Penn Virginia Corporation Provides an Update on Lavaca County Eagle Ford Shale Operations (7:10 AM - Businesswire)

06/08/2012

Last PPS:

$5.39

Gain/Loss:

-1.64%

[

-1.64%

Day

]

Volume:

367.4k

Interest Level:

PVA

NYSE

$5.48

Penn Virginia Corporation Provides an Update on Lavaca County Eagle Ford Shale Operations (7:06 AM - MarketWatch)

06/08/2012

Last PPS:

$5.39

Gain/Loss:

-1.64%

[

-1.64%

Day

]

Volume:

367.4k

Interest Level:

PVA

NYSE

$5.16

pSivida Corp. Announces Issuance of US Patent for Inserter to Be Used in Planned Phase III Uveitis T (8:08 AM - Businesswire)

"...vanced product candidate and based on a consensus arrived upon by the rms and the cms the medicines and Healthcare products regulatory agency of the united kingdom mhra issued its final assessment re...

06/06/2012

Last PPS:

$5.50

Gain/Loss:

6.59%

[

6.59%

Day

]

Volume:

472.5k

Interest Level:

PVA

NYSE

$5.11

pSivida Corp. Announces Portugal Grants ILUVIEN?? Marketing Authorization for the Treatment of Chronic (8:09 AM - Businesswire)

"...oducts for treatment of back of the eye diseases today announced the national authority of medicines and Health products autoridade nacional do medicamento e produtos de sa de infarmed has granted m...

06/05/2012

Last PPS:

$5.16

Gain/Loss:

0.98%

[

0.98%

Day

]

Volume:

570.2k

Interest Level:

PVA

NYSE

$4.93

pSivida Corp. Announces Expiration of 2.7 Million Warrants (8:05 AM - Businesswire)

"...eye diseases today announced the expiration on may 15 2012 of warrants to purchase 2 735 337 shares of psivida Common Stock these were the last of the warrants originally issued to sandell asset manag...

05/17/2012

Last PPS:

$4.95

Gain/Loss:

0.41%

[

0.41%

Day

]

Volume:

831.1k

Interest Level:

PVA

NYSE

$5.51

pSivida Corp. Reports Results for the Third Quarter Ended March 31, 2012 (8:06 AM - Businesswire)

"...zer agreement and increased retisert royalty income the company reported a net loss of 2 7 million or 0 13 Per Share for each of the third quarter periods ended march 31 2012 and 2011 revenu...

05/09/2012

Last PPS:

$5.84

Gain/Loss:

5.99%

[

5.99%

Day

]

Volume:

1.3m

Interest Level: